Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Beta Bionics (BBNX) Cost of Revenue (2024 - 2025)

Beta Bionics (BBNX) has disclosed Cost of Revenue for 2 consecutive years, with $16.3 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 86.65% to $16.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $56.7 million through Dec 2025, up 71.2% year-over-year, with the annual reading at $61.4 million for FY2025, 110.03% up from the prior year.
  • Cost of Revenue hit $16.3 million in Q4 2025 for Beta Bionics, up from $16.0 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $16.3 million in Q4 2025 to a low of $5.7 million in Q1 2024.